Beijing China CICC CITIC Covid-19 Hong Kong Internet Investment IPO Medicine Pandemic Pharmaceutical Revenue Technology Zhejiang
The IPO market in Hong Kong shows little sign of a slowdown with Microport Scientific medtech subsidiary MicroPort CardioFlow and assisted reproduction diagnostics company Basecare Medical likely to push the button over the next week. Both were pre-marketing their initial public offerings to raise up to US$300m and US$250m each. MicroPort CardioFlow's plans were delayed by the Covid-19 pandemic. It had originally intended to float in the first quarter of last year. Back in November, it said that the spin-off which manufactures transcatheter heart valve medical devices, would "unlock value" at a time when MicroPort CardioFlow was growing rapidly and…
News Timeline:
Track the development of this news story across the Internet.